Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
It is a new generation of xanthine oxidase inhibitor developed by Japan's Teijin Company. It is clinically used to treat hyperuricemia (gout). It has the same structure as a xanthine oxidase inhibitor drug developed 40 years ago. Completely different, it is a new and highly effective non-purine xanthine oxidase selective inhibitor. Xanthine oxidase is a key enzyme that promotes the production of uric acid.
Product Categories : API Intermediates > Febuxostat Intermediate
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.